(Q43685655)

25 November 2017

title

Elevations of DNA topoisomerase I in invasive carcinoma of the breast (English)

1 reference

25 November 2017

1 reference

Lynch BJ

1

1 reference

25 November 2017

Bronstein IB

series ordinal

2

1 reference

25 November 2017

Holden JA

series ordinal

3

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

7

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

176-180

1 reference

Clinical applications of the camptothecins.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

A model for the mechanism of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.007003176.X

10.1046/J.1524-4741.2001.007003176.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference